Osteoprotegerin/receptor activator of nuclear factor-kappa B ligand/receptor activator of nuclear factor-kappa B axis in obesity, type 2 diabetes mellitus, and …

ID Vachliotis, SA Polyzos - Current Obesity Reports, 2023 - Springer
Abstract Purpose of Review To summarize evidence on the potential involvement of the
osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B (NF-κΒ) ligand …

Osteocalcin and its potential functions for preventing fatty liver hemorrhagic syndrome in poultry

W Tu, Y Zhang, K Jiang, S Jiang - Animals, 2023 - mdpi.com
Simple Summary Fatty liver hemorrhage syndrome is one of the main metabolic diseases in
laying hens, which leads to lipid accumulation, fragile liver, rupture bleeding, and sudden …

ZnO nanoparticles-modified polycaprolactone-gelatin membranes for guided/bone tissue regeneration, antibacterial and osteogenic differentiation properties

G Prado-Prone, P Silva-Bermudez… - Biomedical Physics …, 2023 - iopscience.iop.org
Periodontitis is a highly prevalent infectious disease that causes the progressive destruction
of the periodontal supporting tissues. If left untreated, it can lead to tooth loss impairing oral …

Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus

D El Amrousy, D El-Afify, A Shabana - Pediatric Research, 2021 - nature.com
Background Oxidative stress in children with type 1 DM (T1DM) may negatively affect the
bone. Methods This study included 40 children with T1DM as the patient group and 40 …

Pro-and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)

A Ullah, RK Singla, Z Batool, D Cao, B Shen - Reviews in Endocrine and …, 2024 - Springer
Childhood obesity is a chronic inflammatory epidemic that affects children worldwide.
Obesity affects approximately 1 in 5 children worldwide. Obesity in children can worsen …

Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe

ME Chondrogianni, I Kyrou, T Androutsakos… - Frontiers in …, 2024 - frontiersin.org
Over the last years non-alcoholic fatty liver disease (NAFLD) has grown into the most
common chronic liver disease globally, affecting 17-38% of the general population and 50 …

[HTML][HTML] Osteocalcin activates lipophagy via the ADPN-AMPK/PPARα-mTOR signaling pathway in chicken embryonic hepatocyte

WJ Tu, YH Zhang, XT Wang, M Zhang, KY Jiang… - Poultry Science, 2024 - Elsevier
Fatty liver hemorrhage syndrome (FLHS) is the leading cause of noninfectious mortality in
caged layers worldwide. Osteocalcin (OCN) is a protein secreted by osteoblasts, and its …

Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis

A Vadarlis, S Chantavaridou, G Kalopitas… - Clinical Nutrition, 2022 - Elsevier
Background & aims Non-alcoholic fatty liver disease (NAFLD) is the most common liver
disease in children and one of the leading indications for liver transplantation in adults …

Decreased serum osteocalcin is an independent risk factor for metabolic dysfunction-associated fatty liver disease in type 2 diabetes

YJ Wang, CH Jin, JF Ke, JW Wang, YL Ma… - … and Obesity: Targets …, 2022 - Taylor & Francis
Purpose The association between serum osteocalcin (OCN) levels and metabolic
dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few …

Osteoprotegerin deficiency aggravates methionine–choline-deficient diet-induced nonalcoholic steatohepatitis in mice

S Wu, Y Wu, L Lin, C Ruan, F Li, R Chen, H Du… - Scientific Reports, 2023 - nature.com
Clinical studies have shown that osteoprotegerin (OPG) is reduced in patients with
nonalcoholic steatohepatitis (NASH), but the underlying mechanisms are unclear. The …